Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions

被引:147
|
作者
Wilson, Garrick K. [1 ]
Tennant, Daniel A. [2 ]
McKeating, Jane A. [1 ,3 ]
机构
[1] Univ Birmingham, Ctr Human Virol, Viral Hepatitis Res Grp, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England
[3] Univ Birmingham, NIHR Liver Biomed Res Unit, Birmingham B15 2TT, W Midlands, England
关键词
Hypoxia; Viral hepatitis; Inflammation; HIF; Liver; ENDOTHELIAL GROWTH-FACTOR; VIRUS-X PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; MITOCHONDRIAL COMPLEX-III; REGULATORY T-CELLS; TISSUE IN-VIVO; HEPATITIS-C; TRANSCRIPTION FACTOR; RAT-LIVER; LYSOPHOSPHATIDIC ACID;
D O I
10.1016/j.jhep.2014.08.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hypoxia inducible transcription factors (HIFs) activate diverse pathways that regulate cellular metabolism, angiogenesis, proliferation, and migration, enabling a cell to respond to a low oxygen or hypoxic environment. HIFs are regulated by oxygen-dependent and independent signals including: mitochondrial dysfunction, reactive oxygen species, endoplasmic reticular stress, and viral infection. HIFs have been reported to play a role in the pathogenesis of liver disease of diverse aetiologies. This review explores the impact of HIFs on hepatocellular biology and inflammatory responses, highlighting the therapeutic potential of targeting HIFs for an array of liver pathologies. (C) 2014 Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver.
引用
收藏
页码:1397 / 1406
页数:10
相关论文
共 50 条
  • [1] Hypoxia inducible factors in hepatocellular carcinoma
    Chen, Chu
    Lou, Tao
    [J]. ONCOTARGET, 2017, 8 (28) : 46691 - 46703
  • [2] Hypoxia-inducible factors in hepatocellular carcinoma
    Guo, Yang
    Xiao, Zunqiang
    Yang, Liu
    Gao, Yuling
    Zhu, Qiaojuan
    Hu, Linjun
    Huang, Dongsheng
    Xu, Qiuran
    [J]. ONCOLOGY REPORTS, 2020, 43 (01) : 3 - 15
  • [3] Hepatocellular Carcinoma: Current Questions and Future Directions
    Gish, Robert G.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (03) : 176 - 179
  • [4] Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
    Perisetti, Abhilash
    Goyal, Hemant
    Yendala, Rachana
    Chandan, Saurabh
    Tharian, Benjamin
    Thandassery, Ragesh Babu
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (04) : 432 - 448
  • [5] Hepatocellular carcinoma surveillance: current practice and future directions
    Ahn, Joseph C.
    Lee, Yi-Te
    Agopian, Vatche G.
    Zhu, Yazhen
    You, Sungyong
    Tseng, Hsian-Rong
    Yang, Ju Dong
    [J]. HEPATOMA RESEARCH, 2022, 8
  • [6] Management of Hepatocellular Carcinoma: Current Status and Future Directions
    Au, Jennifer S.
    Frenette, Catherine T.
    [J]. GUT AND LIVER, 2015, 9 (04) : 437 - 448
  • [7] Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
    Abhilash Perisetti
    Hemant Goyal
    Rachana Yendala
    Saurabh Chandan
    Benjamin Tharian
    Ragesh Babu Thandassery
    [J]. World Journal of Gastroenterology, 2022, (04) : 432 - 448
  • [8] Batten Disease: Current Understanding and Future Directions
    Maria, Bernard L.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2013, 28 (09) : 1072 - 1073
  • [9] Mitochondrial Disease: Current Understanding and Future Directions
    Maria, Bernard L.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2014, 29 (09) : 1177 - 1178
  • [10] Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
    Riccardo Inchingolo
    Alessandro Posa
    Martin Mariappan
    Stavros Spiliopoulos
    [J]. World Journal of Gastroenterology, 2019, 25 (32) : 4614 - 4628